Emtricitabine

Supported by the team of experts, we are the leading Exporter, Manufacturer, Distributor & Supplier of Emtricitabine in Surat, Gujarat, India.
Emtricitabine is indicated in combination with other antiretroviral agents for the treatment of HIV infection in adults. Emtricitabine is commercially available and is approved by the FDA for treatment of HIV infection.

Emtricitabine exhibits clinical activity against the hepatitis B virus (HBV), but is not approved by the FDA for the treatment of HBV infection. Among individuals with chronic HBV infection, emtricitabine treatment results in significant histologic, virologic, and biochemical improvement. The safety profile of emtricitabine during treatment is similar to that of a placebo. Emtricitabine, like all other FDA approved drugs, cures neither HIV nor HBV infection. In a study involving individuals with HBV infection, symptoms of infection returned in 23% of emtricitabine-treated individuals who were taken off therapy.In studies involving individuals with chronic HIV infection, viral replication also resumes when study subjects are taken off therapy.As with drugs used to treat HIV infection, drugs used to treat HBV infection may have to be used in combination to prevent the evolution of drug resistant strains. The effectiveness of emtricitabine in combination with other anti-HBV drugs has not been established.